It has already rising over 160% this year. Its time is now. He likes how analysts see this on an Amazon type of trajectory, with revenues about to soar. They are partnering with Facebook. It is exploring entering into commercial payments beyond the mom and pop type entities he thinks. Yield 0% (Analysts’ price target is $715.11)
It has already rising over 160% this year. Its time is now. He likes how analysts see this on an Amazon type of trajectory, with revenues about to soar. They are partnering with Facebook. It is exploring entering into commercial payments beyond the mom and pop type entities he thinks. Yield 0% (Analysts’ price target is $715.11)
A Canadian healthcare ETF Charges an MER of 0.35%. Healthcare in US election years is vulnerable as candidates target health costs. But industry fundamentals are improving. ZHU consists of 28% healthcare equipment and 22% biotech. To compare, XLV is 35% is pharma and only 13% in biotech.